Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization-Reference-Cited by-同舟云学术

Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization

Published:2018-01-01 Issue:1 Volume:25 Page:1372-1383
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Mu Hongjie¹,Wang Yiyun¹,Chu Yongchao¹,Jiang Ying¹,Hua Hongchen¹,Chu Liuxiang¹,Wang Kaili¹,Wang Aiping¹,Liu Wanhui¹²,Li Youxin¹²,Fu Fenghua¹²,Sun Kaoxiang¹

Affiliation:

1. School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Yantai University, Yantai, Shandong Province, People’s Republic of China;

2. State Key Laboratory of Long-Acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co., Ltd., Yantai, Shandong Province, People’s Republic of China

Funder

Natural Science Foundation of Shandong Province

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2018.1474967

Reference46 articles.

1. PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION

2. Topology of Multivesicular Liposomes, a Model Biliquid Foam

3. Electrospun formulations of bevacizumab for sustained release in the eye